Here's a look at the top stocks that may hog the limelight in today's session:

Here is a list of stocks that are likely to be in focus in today's trading session.

Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Nystatin Ointment USP, 1...

Weak signals from global markets and some key data releases may chart market direction.

Dr Reddy's Laboratories' shares today were trading at Rs 3,178.70 in the morning trade on the BSE, down 0.03 per cent.

Glenmark Pharmaceuticals USA has been granted final approval by the US Food & Drug Administration (USFDA) for the "nystatin and triamcinolo...

Glenmark Pharmaceuticals Inc has been granted final approval by the US Food and Drug Administration (USFDA) for nystatin and triamcinolone ...

"Lupin would have a stable revenue growth merely because some of the recent launches that they have had have been in the latter part of the...

ET Now spoke to dealers on institutional and HNI's activity in the dealing room. These stocks were on their radar on unconfirmed reports.

Elara Capital is of the view that current valuations of the company are rich and has maintained its ‘accumulate’ rating with target price o...